SEC Form 4 · accession 0000950138-16-001183
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Meredith B Fischer
Officer — Sr. VP, Comm & Public Affairs
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 1, 2016 | F | 531 | $61.84 | D | 17,612 | D |
Table II — derivative securities
No Table II lines on this filing.